BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Summerlin N, Qu Z, Pujara N, Sheng Y, Jambhrunkar S, Mcguckin M, Popat A. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol. Colloids and Surfaces B: Biointerfaces 2016;144:1-7. [DOI: 10.1016/j.colsurfb.2016.03.076] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 11.9] [Reference Citation Analysis]
Number Citing Articles
1 Wu T, Zhang X, Liu Y, Cui C, Sun Y, Liu W. Wet adhesive hydrogel cardiac patch loaded with anti-oxidative, autophagy-regulating molecule capsules and MSCs for restoring infarcted myocardium. Bioactive Materials 2023;21:20-31. [DOI: 10.1016/j.bioactmat.2022.07.029] [Reference Citation Analysis]
2 Peng S, Wang Y, Sun Z, Zhao L, Huang Y, Fu X, Luo R, Xue J, Yang S, Ling L, Zhang Z. Nanoparticles loaded with pharmacologically active plant-derived natural products: Biomedical applications and toxicity. Colloids Surf B Biointerfaces 2023;225:113214. [PMID: 36893664 DOI: 10.1016/j.colsurfb.2023.113214] [Reference Citation Analysis]
3 Quiñonero F, Mesas C, Peña M, Cabeza L, Perazzoli G, Melguizo C, Ortiz R, Prados J. Vegetal-Derived Bioactive Compounds as Multidrug Resistance Modulators in Colorectal Cancer. Applied Sciences 2023;13:2667. [DOI: 10.3390/app13042667] [Reference Citation Analysis]
4 Qin L, Jing G, Cui N, Xu Z, He Y, Qin Y, Lu T, Sun J, Du A, Wang S. Resveratrol-silica aerogel nanodrug complex system enhances the treatment of sports osteoarthritis by activating SIRT-1. Adv Compos Hybrid Mater 2023;6:3. [DOI: 10.1007/s42114-022-00576-2] [Reference Citation Analysis]
5 Salve R, Kumar P, Chaudhari BP, Gajbhiye V. Aptamer Tethered Bio-Responsive Mesoporous Silica Nanoparticles for Efficient Targeted Delivery of Paclitaxel to Treat Ovarian Cancer Cells. J Pharm Sci 2023:S0022-3549(23)00013-8. [PMID: 36669561 DOI: 10.1016/j.xphs.2023.01.011] [Reference Citation Analysis]
6 Zhu W, Dong Y, Xu P, Pan Q, Jia K, Jin P, Zhou M, Xu Y, Guo R, Cheng B. A composite hydrogel containing resveratrol-laden nanoparticles and platelet-derived extracellular vesicles promotes wound healing in diabetic mice. Acta Biomater 2022;154:212-30. [PMID: 36309190 DOI: 10.1016/j.actbio.2022.10.038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Naeimi R, Najafi R, Molaei P, Amini R, Pecic S. Nanoparticles: The future of effective diagnosis and treatment of colorectal cancer? European Journal of Pharmacology 2022;936:175350. [DOI: 10.1016/j.ejphar.2022.175350] [Reference Citation Analysis]
8 Eskandani R, Kazempour M, Farahzadi R, Sanaat Z, Eskandani M, Adibkia K, Vandghanooni S, Mokhtarzadeh A. Engineered nanoparticles as emerging gene/drug delivery systems targeting the nuclear factor-κB protein and related signaling pathways in cancer. Biomedicine & Pharmacotherapy 2022;156:113932. [DOI: 10.1016/j.biopha.2022.113932] [Reference Citation Analysis]
9 Bhartiya P, Chawla R, Dutta PK. Folate receptor targeted chitosan and polydopamine coated mesoporous silica nanoparticles for photothermal therapy and drug delivery. Journal of Macromolecular Science, Part A. [DOI: 10.1080/10601325.2022.2135443] [Reference Citation Analysis]
10 Ju J, Wu Y, He W, Zhan L, Yin X, Zhang J, Zhang Y, Qiu L, Muhammad P, Reis RL, Li C. Nanocarriers for Active Ingredients of Chinese Medicine (AIFCM) Used in Gastrointestinal Cancer Therapy. j biomed nanotechnol 2022;18:2279-2314. [DOI: 10.1166/jbn.2022.3446] [Reference Citation Analysis]
11 Sabu C, Ameena Shirin V, Sankar R, Pramod K. Inorganic Nanoparticles for Drug‐delivery Applications. Nanomaterials and Nanotechnology in Medicine 2022. [DOI: 10.1002/9781119558026.ch14] [Reference Citation Analysis]
12 Yu H, Liu Y, Zheng F, Chen W, Wei K. Erianin-Loaded Photo-Responsive Dendrimer Mesoporous Silica Nanoparticles: Exploration of a Psoriasis Treatment Method. Molecules 2022;27:6328. [DOI: 10.3390/molecules27196328] [Reference Citation Analysis]
13 Gu Y, Fei Z, Ding X. Mesoporous Silica Nanoparticles Loaded with Resveratrol Are Used for Targeted Breast Cancer Therapy. Journal of Oncology 2022;2022:1-11. [DOI: 10.1155/2022/8471331] [Reference Citation Analysis]
14 Wang M, Liu X, Chen T, Cheng X, Xiao H, Meng X, Jiang Y. Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways. Front Oncol 2022;12:956793. [DOI: 10.3389/fonc.2022.956793] [Reference Citation Analysis]
15 Pinilla-peñalver E, García-béjar B, Contento AM, Ríos Á. Graphene quantum dots an efficient nanomaterial for enhancing the photostability of trans-resveratrol in food samples. Food Chemistry 2022;386:132766. [DOI: 10.1016/j.foodchem.2022.132766] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mehmood S, Maqsood M, Mahtab N, Khan MI, Sahar A, Zaib S, Gul S. Epigallocatechin gallate: Phytochemistry, bioavailability, utilization challenges, and strategies. J Food Biochem 2022;:e14189. [PMID: 35474461 DOI: 10.1111/jfbc.14189] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Hinge NS, Kathuria H, Pandey MM. Engineering of structural and functional properties of nanotherapeutics and nanodiagnostics for intranasal brain targeting in Alzheimer's. Applied Materials Today 2022;26:101303. [DOI: 10.1016/j.apmt.2021.101303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Ioniţă S, Lincu D, Mitran R, Ziko L, Sedky NK, Deaconu M, Brezoiu A, Matei C, Berger D. Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers. Pharmaceutics 2022;14:203. [DOI: 10.3390/pharmaceutics14010203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
19 Al-Joufi FA, Setia A, Salem-Bekhit MM, Sahu RK, Alqahtani FY, Widyowati R, Aleanizy FS. Molecular Pathogenesis of Colorectal Cancer with an Emphasis on Recent Advances in Biomarkers, as Well as Nanotechnology-Based Diagnostic and Therapeutic Approaches. Nanomaterials (Basel) 2022;12:169. [PMID: 35010119 DOI: 10.3390/nano12010169] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 19.0] [Reference Citation Analysis]
20 Riaz A, Zara R, Bushra G, Kanwal N, Sadiqa A, Shareef F, Sarfraz I, Shah MA, Ucak I, Bukhari SA, Rasul A. Cancer metabolism regulation by phytonutrients. The Role of Phytonutrients in Metabolic Disorders 2022. [DOI: 10.1016/b978-0-12-824356-5.00002-3] [Reference Citation Analysis]
21 Parekh K, Hariharan K, Qu Z, Rewatkar P, Cao Y, Moniruzzaman M, Pandey P, Popat A, Mehta T. Tacrolimus encapsulated mesoporous silica nanoparticles embedded hydrogel for the treatment of atopic dermatitis. Int J Pharm 2021;608:121079. [PMID: 34500058 DOI: 10.1016/j.ijpharm.2021.121079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Krechetov SP, Maslennikova MS, Solovieva NL, Krasnyuk II. DEVELOPMENT OF OPTIMAL COMPOSITION FORMULATION OF RESVERATROL AND SOLUBILISERS. Rossijskij bioterapevtičeskij žurnal 2021;20:57-65. [DOI: 10.17650/1726-9784-2021-20-3-57-65] [Reference Citation Analysis]
23 Rashidi L. Different nano-delivery systems for delivery of nutraceuticals. Food Bioscience 2021;43:101258. [DOI: 10.1016/j.fbio.2021.101258] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
24 Chen Z, Farag MA, Zhong Z, Zhang C, Yang Y, Wang S, Wang Y. Multifaceted role of phyto-derived polyphenols in nanodrug delivery systems. Advanced Drug Delivery Reviews 2021;176:113870. [DOI: 10.1016/j.addr.2021.113870] [Cited by in Crossref: 37] [Cited by in F6Publishing: 20] [Article Influence: 18.5] [Reference Citation Analysis]
25 Ang CW, Tan L, Qu Z, West NP, Cooper MA, Popat A, Blaskovich MAT. Mesoporous Silica Nanoparticles Improve Oral Delivery of Antitubercular Bicyclic Nitroimidazoles. ACS Biomater Sci Eng 2021. [PMID: 34464089 DOI: 10.1021/acsbiomaterials.1c00807] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
26 Morante-zarcero S, Endrino A, Casado N, Pérez-quintanilla D, Sierra I. Evaluation of mesostructured silica materials with different structures and morphologies as carriers for quercetin and naringin encapsulation. J Porous Mater 2022;29:33-48. [DOI: 10.1007/s10934-021-01144-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Rinaldi F, Maurizi L, Forte J, Marazzato M, Hanieh PN, Conte AL, Ammendolia MG, Marianecci C, Carafa M, Longhi C. Resveratrol-Loaded Nanoemulsions: In Vitro Activity on Human T24 Bladder Cancer Cells. Nanomaterials (Basel) 2021;11:1569. [PMID: 34203613 DOI: 10.3390/nano11061569] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
28 Qiao L, Han M, Gao S, Shao X, Wang X, Sun L, Fu X, Wei Q. Research progress on nanotechnology for delivery of active ingredients from traditional Chinese medicines. J Mater Chem B 2020;8:6333-51. [PMID: 32633311 DOI: 10.1039/d0tb01260b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
29 Janjua TI, Rewatkar P, Ahmed-Cox A, Saeed I, Mansfeld FM, Kulshreshtha R, Kumeria T, Ziegler DS, Kavallaris M, Mazzieri R, Popat A. Frontiers in the treatment of glioblastoma: Past, present and emerging. Adv Drug Deliv Rev 2021;171:108-38. [PMID: 33486006 DOI: 10.1016/j.addr.2021.01.012] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 23.5] [Reference Citation Analysis]
30 Annaji M, Poudel I, Boddu SHS, Arnold RD, Tiwari AK, Babu RJ. Resveratrol-loaded nanomedicines for cancer applications. Cancer Rep (Hoboken) 2021;4:e1353. [PMID: 33655717 DOI: 10.1002/cnr2.1353] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
31 Pavitra E, Dariya B, Srivani G, Kang SM, Alam A, Sudhir PR, Kamal MA, Raju GSR, Han YK, Lakkakula BVKS, Nagaraju GP, Huh YS. Engineered nanoparticles for imaging and drug delivery in colorectal cancer. Semin Cancer Biol 2021;69:293-306. [PMID: 31260733 DOI: 10.1016/j.semcancer.2019.06.017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 15.5] [Reference Citation Analysis]
32 Sha X, Dai Y, Song X, Liu S, Zhang S, Li J. The Opportunities and Challenges of Silica Nanomaterial for Atherosclerosis. Int J Nanomedicine 2021;16:701-14. [PMID: 33536755 DOI: 10.2147/IJN.S290537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
33 AbouAitah K, Lojkowski W. Delivery of Natural Agents by Means of Mesoporous Silica Nanospheres as a Promising Anticancer Strategy. Pharmaceutics 2021;13:143. [PMID: 33499150 DOI: 10.3390/pharmaceutics13020143] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
34 Tomar D, Singh PK, Hoque S, Modani S, Sriram A, Kumar R, Madan J, Khatri D, Dua K. Amorphous systems for delivery of nutraceuticals: challenges opportunities. Crit Rev Food Sci Nutr 2020;:1-18. [PMID: 33103462 DOI: 10.1080/10408398.2020.1836607] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
35 Buda V, Brezoiu AM, Berger D, Pavel IZ, Muntean D, Minda D, Dehelean CA, Soica C, Diaconeasa Z, Folescu R, Danciu C. Biological Evaluation of Black Chokeberry Extract Free and Embedded in Two Mesoporous Silica-Type Matrices. Pharmaceutics 2020;12:E838. [PMID: 32882983 DOI: 10.3390/pharmaceutics12090838] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
36 Meena J, Gupta A, Ahuja R, Singh M, Bhaskar S, Panda AK. Inorganic nanoparticles for natural product delivery: a review. Environ Chem Lett 2020;18:2107-18. [DOI: 10.1007/s10311-020-01061-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
37 Machado ND, Fernández MA, Díaz DD. Recent Strategies in Resveratrol Delivery Systems. Chempluschem 2019;84:951-73. [PMID: 31943987 DOI: 10.1002/cplu.201900267] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 9.3] [Reference Citation Analysis]
38 Lin YC, Hu SC, Huang PH, Lin TC, Yen FL. Electrospun Resveratrol-Loaded Polyvinylpyrrolidone/Cyclodextrin Nanofibers and Their Biomedical Applications. Pharmaceutics 2020;12:E552. [PMID: 32545836 DOI: 10.3390/pharmaceutics12060552] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
39 Juère E, Del Favero G, Masse F, Marko D, Popat A, Florek J, Caillard R, Kleitz F. Gastro-protective protein-silica nanoparticles formulation for oral drug delivery: In vitro release, cytotoxicity and mitochondrial activity. European Journal of Pharmaceutics and Biopharmaceutics 2020;151:171-80. [DOI: 10.1016/j.ejpb.2020.03.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
40 Mo C, Lu L, Liu D, Wei K. Development of erianin-loaded dendritic mesoporous silica nanospheres with pro-apoptotic effects and enhanced topical delivery. J Nanobiotechnology 2020;18:55. [PMID: 32228604 DOI: 10.1186/s12951-020-00608-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
41 Forbes-hernández TY, Wang L. Berries polyphenols: Nano-delivery systems to improve their potential in cancer therapy. JBR 2020;10:45-60. [DOI: 10.3233/jbr-200547] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
42 Rewatkar P, Kumeria T, Popat A. Size, shape and surface charge considerations of orally delivered nanomedicines. Nanotechnology for Oral Drug Delivery. Elsevier; 2020. pp. 143-76. [DOI: 10.1016/b978-0-12-818038-9.00005-3] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Abdel Samie SM, Nasr M. Food to medicine transformation of stilbenoid vesicular and lipid-based nanocarriers: Technological advances. Drug Delivery Aspects 2020. [DOI: 10.1016/b978-0-12-821222-6.00011-7] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
44 Meena J, Gupta A, Ahuja R, Panda AK, Bhaskar S. Inorganic Particles for Delivering Natural Products. Sustainable Agriculture Reviews 2020. [DOI: 10.1007/978-3-030-41842-7_6] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
45 Vervandier-Fasseur D, Latruffe N. The Potential Use of Resveratrol for Cancer Prevention. Molecules 2019;24:E4506. [PMID: 31835371 DOI: 10.3390/molecules24244506] [Cited by in Crossref: 50] [Cited by in F6Publishing: 60] [Article Influence: 12.5] [Reference Citation Analysis]
46 Ackova DG, Smilkov K, Bosnakovski D. Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds. Recent Pat Anticancer Drug Discov 2019;14:19-31. [PMID: 30636616 DOI: 10.2174/1574892814666190111104834] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
47 Cui H, Chen X, Bai M, Han D, Lin L, Dong M. Multipathway Antibacterial Mechanism of a Nanoparticle-Supported Artemisinin Promoted by Nitrogen Plasma Treatment. ACS Appl Mater Interfaces 2019;11:47299-310. [DOI: 10.1021/acsami.9b15124] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
48 Shao M, Chang C, Liu Z, Chen K, Zhou Y, Zheng G, Huang Z, Xu H, Xu P, Lu B. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance. Colloids and Surfaces B: Biointerfaces 2019;183:110427. [DOI: 10.1016/j.colsurfb.2019.110427] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 10.5] [Reference Citation Analysis]
49 Diaz M, Parikh V, Ismail S, Maxamed R, Tye E, Austin C, Dew T, Graf BA, Vanhees L, Degens H, Azzawi M. Differential effects of resveratrol on the dilator responses of femoral arteries, ex vivo. Nitric Oxide 2019;92:1-10. [DOI: 10.1016/j.niox.2019.07.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
50 Chirra S, Siliveri S, Gangalla R, Goskula S, Gujjula SR, Adepu AK, Anumula R, Sivasoorian SS, Wang LF, Narayanan V. Synthesis of new multivalent metal ion functionalized mesoporous silica and studies of their enhanced antimicrobial and cytotoxicity activities. J Mater Chem B 2019;7:7235-45. [PMID: 31664291 DOI: 10.1039/c9tb01736d] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
51 Chaudhary Z, Subramaniam S, Khan GM, Abeer MM, Qu Z, Janjua T, Kumeria T, Batra J, Popat A. Encapsulation and Controlled Release of Resveratrol Within Functionalized Mesoporous Silica Nanoparticles for Prostate Cancer Therapy. Front Bioeng Biotechnol 2019;7:225. [PMID: 31620434 DOI: 10.3389/fbioe.2019.00225] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 16.3] [Reference Citation Analysis]
52 Fan C, Kong F, Shetti D, Zhang B, Yang Y, Wei K. Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer. Biochem Biophys Res Commun 2019;519:378-84. [PMID: 31519327 DOI: 10.1016/j.bbrc.2019.09.016] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
53 Miele D, Catenacci L, Sorrenti M, Rossi S, Sandri G, Malavasi L, Dacarro G, Ferrari F, Bonferoni MC. Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol. Mar Drugs 2019;17:E515. [PMID: 31480614 DOI: 10.3390/md17090515] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
54 Salem HF, Kharshoum RM, Abou-Taleb HA, Naguib DM. Nanosized nasal emulgel of resveratrol: preparation, optimization, in vitro evaluation and in vivo pharmacokinetic study. Drug Dev Ind Pharm 2019;45:1624-34. [PMID: 31353967 DOI: 10.1080/03639045.2019.1648500] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
55 Ahmadi Z, Mohammadinejad R, Ashrafizadeh M. Drug delivery systems for resveratrol, a non-flavonoid polyphenol: Emerging evidence in last decades. Journal of Drug Delivery Science and Technology 2019;51:591-604. [DOI: 10.1016/j.jddst.2019.03.017] [Cited by in Crossref: 71] [Cited by in F6Publishing: 45] [Article Influence: 17.8] [Reference Citation Analysis]
56 Xiong S, Liu W, Zhou Y, Mo Y, Liu Y, Chen X, Pan H, Yuan D, Wang Q, Chen T. Enhancement of oral bioavailability and anti-Parkinsonian efficacy of resveratrol through a nanocrystal formulation. Asian J Pharm Sci 2020;15:518-28. [PMID: 32952674 DOI: 10.1016/j.ajps.2019.04.003] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
57 Shin C, Choi J, Kwak D, Kim J, Yang J, Chae S, Kim T. Evaluation of Size Distribution Measurement Methods for Sub-100 nm Colloidal Silica Nanoparticles and Its Application to CMP Slurry. ECS J Solid State Sci Technol 2019;8:P3195-200. [DOI: 10.1149/2.0261905jss] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
58 Salem HF, Kharshoum RM, Abou-Taleb HA, Naguib DM. Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study. AAPS PharmSciTech 2019;20:181. [PMID: 31049748 DOI: 10.1208/s12249-019-1353-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
59 Jampilek J, Kos J, Kralova K. Potential of Nanomaterial Applications in Dietary Supplements and Foods for Special Medical Purposes. Nanomaterials (Basel) 2019;9:E296. [PMID: 30791492 DOI: 10.3390/nano9020296] [Cited by in Crossref: 90] [Cited by in F6Publishing: 93] [Article Influence: 22.5] [Reference Citation Analysis]
60 Li Z, Zhang Y, Feng N. Mesoporous silica nanoparticles: synthesis, classification, drug loading, pharmacokinetics, biocompatibility, and application in drug delivery. Expert Opinion on Drug Delivery 2019;16:219-37. [DOI: 10.1080/17425247.2019.1575806] [Cited by in Crossref: 136] [Cited by in F6Publishing: 111] [Article Influence: 34.0] [Reference Citation Analysis]
61 Tabibiazar M, Mohammadifar MA, Roufegarinejad L, Ghorbani M, Hashemi M, Hamishehkar H. Improvement in dispersibility, stability and antioxidant activity of resveratrol using a colloidal nanodispersion of BSA-resveratrol. Food Bioscience 2019;27:46-53. [DOI: 10.1016/j.fbio.2018.10.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
62 Saroj S, Rajput SJ. Etoposide encased folic acid adorned mesoporous silica nanoparticles as potent nanovehicles for enhanced prostate cancer therapy: synthesis, characterization, cellular uptake and biodistribution. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:S1115-30. [DOI: 10.1080/21691401.2018.1533843] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
63 Meka AK, Jenkins LJ, Dàvalos-Salas M, Pujara N, Wong KY, Kumeria T, Mariadason JM, Popat A. Enhanced Solubility, Permeability and Anticancer Activity of Vorinostat Using Tailored Mesoporous Silica Nanoparticles. Pharmaceutics 2018;10:E283. [PMID: 30562958 DOI: 10.3390/pharmaceutics10040283] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
64 Florek J, Caillard R, Kleitz F. Evaluation of mesoporous silica nanoparticles for oral drug delivery - current status and perspective of MSNs drug carriers. Nanoscale. 2017;9:15252-15277. [PMID: 28984885 DOI: 10.1039/c7nr05762h] [Cited by in Crossref: 132] [Cited by in F6Publishing: 136] [Article Influence: 26.4] [Reference Citation Analysis]
65 Jafari S, Derakhshankhah H, Alaei L, Fattahi A, Varnamkhasti BS, Saboury AA. Mesoporous silica nanoparticles for therapeutic/diagnostic applications. Biomed Pharmacother 2019;109:1100-11. [PMID: 30551360 DOI: 10.1016/j.biopha.2018.10.167] [Cited by in Crossref: 203] [Cited by in F6Publishing: 214] [Article Influence: 40.6] [Reference Citation Analysis]
66 Giovaninni G, Moore CJ, Hall AJ, Byrne HJ, Gubala V. pH-Dependent silica nanoparticle dissolution and cargo release. Colloids and Surfaces B: Biointerfaces 2018;169:242-8. [DOI: 10.1016/j.colsurfb.2018.04.064] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
67 Li Z, Zhang Y, Zhang K, Wu Z, Feng N. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:578-87. [DOI: 10.1080/21691401.2018.1431651] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
68 Pattnaik S, Swain K. Mesoporous nanomaterials as carriers in drug delivery. Applications of Nanocomposite Materials in Drug Delivery 2018. [DOI: 10.1016/b978-0-12-813741-3.00025-x] [Cited by in Crossref: 4] [Article Influence: 0.8] [Reference Citation Analysis]
69 Chen C, Sun W, Wang X, Wang Y, Wang P. Rational design of curcumin loaded multifunctional mesoporous silica nanoparticles to enhance the cytotoxicity for targeted and controlled drug release. Mater Sci Eng C Mater Biol Appl 2018;85:88-96. [PMID: 29407161 DOI: 10.1016/j.msec.2017.12.007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
70 Juère E, Florek J, Bouchoucha M, Jambhrunkar S, Wong KY, Popat A, Kleitz F. In Vitro Dissolution, Cellular Membrane Permeability, and Anti-Inflammatory Response of Resveratrol-Encapsulated Mesoporous Silica Nanoparticles. Mol Pharm 2017;14:4431-41. [PMID: 29094948 DOI: 10.1021/acs.molpharmaceut.7b00529] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 10.3] [Reference Citation Analysis]
71 Mebert AM, Baglole CJ, Desimone MF, Maysinger D. Nanoengineered silica: Properties, applications and toxicity. Food and Chemical Toxicology 2017;109:753-70. [DOI: 10.1016/j.fct.2017.05.054] [Cited by in Crossref: 96] [Cited by in F6Publishing: 77] [Article Influence: 16.0] [Reference Citation Analysis]
72 Jadhav NV, Vavia PR. Dodecylamine Template-Based Hexagonal Mesoporous Silica (HMS) as a Carrier for Improved Oral Delivery of Fenofibrate. AAPS PharmSciTech 2017;18:2764-73. [PMID: 28353172 DOI: 10.1208/s12249-017-0761-x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
73 Abdel-bar HM, el Basset Sanad RA. Endocytic pathways of optimized resveratrol cubosomes capturing into human hepatoma cells. Biomedicine & Pharmacotherapy 2017;93:561-9. [DOI: 10.1016/j.biopha.2017.06.093] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
74 Arora D, Jaglan S. Therapeutic applications of resveratrol nanoformulations. Environ Chem Lett 2018;16:35-41. [DOI: 10.1007/s10311-017-0660-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
75 Khanfar M, Al-Nimry S. Stabilization and Amorphization of Lovastatin Using Different Types of Silica. AAPS PharmSciTech 2017;18:2358-67. [PMID: 28127721 DOI: 10.1208/s12249-017-0717-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
76 Cheng MF, Lin SR, Tseng FJ, Huang YC, Tsai MJ, Fu YS, Weng CF. The autophagic inhibition oral squamous cell carcinoma cancer growth of 16-hydroxy-cleroda-3,14-dine-15,16-olide. Oncotarget 2017;8:78379-96. [PMID: 29108236 DOI: 10.18632/oncotarget.18987] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
77 Bonferoni MC, Rossi S, Sandri G, Ferrari F. Nanoparticle formulations to enhance tumor targeting of poorly soluble polyphenols with potential anticancer properties. Semin Cancer Biol 2017;46:205-14. [PMID: 28673607 DOI: 10.1016/j.semcancer.2017.06.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 9.5] [Reference Citation Analysis]
78 Fonseca DP, Khalil NM, Mainardes RM. Bovine serum albumin-based nanoparticles containing resveratrol: Characterization and antioxidant activity. Journal of Drug Delivery Science and Technology 2017;39:147-55. [DOI: 10.1016/j.jddst.2017.03.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 5.3] [Reference Citation Analysis]
79 Huang PK, Lin SX, Tsai MJ, Leong MK, Lin SR, Kankala RK, Lee CH, Weng CF. Encapsulation of 16-Hydroxycleroda-3,13-Dine-16,15-Olide in Mesoporous Silica Nanoparticles as a Natural Dipeptidyl Peptidase-4 Inhibitor Potentiated Hypoglycemia in Diabetic Mice. Nanomaterials (Basel) 2017;7:E112. [PMID: 28498352 DOI: 10.3390/nano7050112] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
80 Kanth VR, Kajjari PB, Madalageri PM, Ravindra S, Manjeshwar LS, Aminabhavi TM. Blend Hydrogel Microspheres of Carboxymethyl Chitosan and Gelatin for the Controlled Release of 5-Fluorouracil. Pharmaceutics 2017;9:E13. [PMID: 28346376 DOI: 10.3390/pharmaceutics9020013] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
81 Cui H, Yuan L, Li W, Lin L. Antioxidant property of SiO2-eugenol liposome loaded nanofibrous membranes on beef. Food Packaging and Shelf Life 2017;11:49-57. [DOI: 10.1016/j.fpsl.2017.01.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
82 Mamadou G, Charrueau C, Dairou J, Limas Nzouzi N, Eto B, Ponchel G. Increased intestinal permeation and modulation of presystemic metabolism of resveratrol formulated into self-emulsifying drug delivery systems. Int J Pharm 2017;521:150-5. [PMID: 28216465 DOI: 10.1016/j.ijpharm.2017.02.036] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
83 Arora D, Jaglan S. Nanocarriers for Resveratrol Delivery. Sustainable Agriculture Reviews 2017. [DOI: 10.1007/978-3-319-58496-6_5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
84 Tyagi N, De R, Begun J, Popat A. Cancer therapeutics with epigallocatechin-3-gallate encapsulated in biopolymeric nanoparticles. Int J Pharm 2017;518:220-7. [PMID: 27988378 DOI: 10.1016/j.ijpharm.2016.12.030] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 5.1] [Reference Citation Analysis]
85 Pujara N, Jambhrunkar S, Wong KY, McGuckin M, Popat A. Enhanced colloidal stability, solubility and rapid dissolution of resveratrol by nanocomplexation with soy protein isolate. J Colloid Interface Sci 2017;488:303-8. [PMID: 27838554 DOI: 10.1016/j.jcis.2016.11.015] [Cited by in Crossref: 98] [Cited by in F6Publishing: 105] [Article Influence: 14.0] [Reference Citation Analysis]
86 Xin Y, Liu T, Yang C. Development of PLGA-lipid nanoparticles with covalently conjugated indocyanine green as a versatile nanoplatform for tumor-targeted imaging and drug delivery. Int J Nanomedicine 2016;11:5807-21. [PMID: 27853366 DOI: 10.2147/IJN.S119999] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
87 Hao J, Zhao J, Zhang S, Tong T, Zhuang Q, Jin K, Chen W, Tang H. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery. Colloids Surf B Biointerfaces 2016;147:376-86. [PMID: 27566226 DOI: 10.1016/j.colsurfb.2016.08.011] [Cited by in Crossref: 82] [Cited by in F6Publishing: 82] [Article Influence: 11.7] [Reference Citation Analysis]
88 Costa MP, Feitosa AC, Oliveira FC, Cavalcanti BC, da Silva EN, Dias GG, Sales FA, Sousa BL, Barroso-Neto IL, Pessoa C, Caetano EW, Di Fiore S, Fischer R, Ladeira LO, Freire VN. Controlled Release of Nor-β-lapachone by PLGA Microparticles: A Strategy for Improving Cytotoxicity against Prostate Cancer Cells. Molecules 2016;21:E873. [PMID: 27384551 DOI: 10.3390/molecules21070873] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]